Genaissance Pharmaceuticals, University of Utah, Yale, Hycor Biomedical, University of Louisville, Tm Bioscience, Lexicon Genetics, Decode Genetics | GenomeWeb

Genaissance Amends License Deal with University of Utah, Yale

Genaissance Pharmaceuticals has amended a license agreement with the University of Utah and Yale University relating to cardiac ion channel genes associated with sudden cardiac death syndromes, the company announced last week.

The amendment relates to more than 50 issued and pending patents Genaissance licensed in the United States and other countries that cover five cardiac ion channel genes associated with Long QT, Brugada, and related syndromes

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.